Gujarat Themis Biosyn Ltd. moves to reshape its capital structure

Current cash-to-debt: The latest Q1 FY27 standalone debt figures imply cash of Rs 3.12 Crores: total debt was Rs 159.86 Crores and net debt Rs 156.74 Crores ^{[7] [8]}. Therefore:

`cash-to-debt = Rs 3.12 Crores / Rs 159.86 Crores = 0.02x, or 1.95%`

This is a very thin cash cushion relative to gross debt. The cash figure is derived because a Q1 FY27 cash-line value is not separately populated; it also matches the FY26 reported cash balance of Rs 3.12 Crores ^[9].

Dividend versus free cash flow: The approved dividend is Rs 0.67 per share, aggregating to Rs 8.72 Crores for FY26 ^[1]. The stated 67% is the dividend rate on the Rs 1 face value, not the earnings payout ratio. Against FY26 standalone PAT of Rs 46.68 Crores ^[10], the implied earnings payout ratio is approximately 18.68%.

That payout is not supported by recent free cash flow generation:

• FY25 FCF: Rs 91.03 Crores operating cash flow less Rs 116.15 Crores capex = negative Rs 25.12 Crores ^{[11] [12]}.
• FY26 FCF: Rs 48.78 Crores operating cash flow less Rs 172.53 Crores capex = negative Rs 123.75 Crores ^{[11] [12]}.

Accordingly, the dividend is moderate relative to accounting profit but not FCF-covered; its payment coincides with a low cash-to-debt position and substantial capital expenditure. The preferential issue may replenish the capital base, but the filing does not specify the issue size or proceeds, and approval alone does not change the current ratio.

Verdict: The AOA change is a targeted financing-related governance amendment, not an amendment to the company’s authorized share capital. The preferential issue was approved as a separate item; the AOA change appears designed to accommodate rights that financing institutions or investors may receive under transaction agreements. ^[1]

The amendment to Article 119:

• Removes the phrase “as such term is defined in the Act.”
• Adds a conditional right for a “Financial Institution” to appoint and remove a board observer while loans, debentures, guarantees, or shares held through underwriting, subscription, or private placement remain outstanding. ^[13]
• Defines “Financial Institution” broadly to include investors, banks, funds, lending institutions, lenders, and similar entities or persons. ^[13]

Implication for the preferential issue: The filing does not say that the AOA amendment increases authorized share capital or is a direct legal prerequisite for the preferential issue. It is therefore better read as supporting the financing framework around the issue, rather than authorizing the issue itself. The preferential equity issuance was separately approved by shareholders. ^[1]

Implication for future capital allocation: The amendment is broader than a one-off preferential-issue procedural change because it can apply to future debt or equity financing arrangements involving qualifying financial institutions. However, its impact is principally on financing-party oversight and transaction terms: the stated right is to appoint a board observer while the relevant obligations or holdings remain outstanding. The disclosed text does not describe a change in authorized share capital, a general alteration of voting rights, or a broad restructuring of board powers. ^[13]

Accordingly, the capital-allocation risk is indirect: future financing may come with observer rights and other terms in transaction agreements. The filing does not establish any new authorized-capital headroom or disclose that the observer would have voting, veto, or allocation-approval rights.